Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results

被引：0
|
作者：
Makoto Ueno
Masafumi Ikeda
Takashi Sasaki
Fumio Nagashima
Nobumasa Mizuno
Satoshi Shimizu
Hiroki Ikezawa
Nozomi Hayata
Ryo Nakajima
Chigusa Morizane
机构：
[1] Kanagawa Cancer Centre Hospital,Department of Hepatobiliary and Pancreatic Oncology
[2] National Cancer Center Hospital East,undefined
[3] Cancer Institute Hospital of JFCR,undefined
[4] Kyorin University,undefined
[5] Aichi Cancer Centre Hospital,undefined
[6] Saitama Cancer Centre,undefined
[7] Eisai Co. Ltd.,undefined
[8] Eisai Inc.,undefined
[9] National Cancer Centre Hospital,undefined
来源：
BMC Cancer | / 20卷
关键词：
Lenvatinib; Biliary tract cancer; Cholangiocarcinoma; Gallbladder cancer; Ampulla of Vater;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results
    Ueno, Makoto
    Ikeda, Masafumi
    Sasaki, Takashi
    Nagashima, Fumio
    Mizuno, Nobumasa
    Shimizu, Satoshi
    Ikezawa, Hiroki
    Hayata, Nozomi
    Nakajima, Ryo
    Morizane, Chigusa
    BMC CANCER, 2020, 20 (01)
  • [2] A phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: Primary analysis results
    Ikeda, M.
    Sasaki, T.
    Morizane, C.
    Mizuno, N.
    Nagashima, F.
    Shimizu, S.
    Hayata, N.
    Ikezawa, H.
    Suzuki, T.
    Nakajima, R.
    Dutcus, C.
    Ueno, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] A Phase II Study of Lenvatinib Monotherapy as Second-Line Treatment in Unresectable Biliary Tract Cancer: Primary Analysis Results
    Ikeda, Masafumi
    Sasaki, Takashi
    Morizane, Chigusa
    Mizuno, Nobumasa
    Nagashima, Fumio
    Shimizu, Satoshi
    Hayata, Nozomi
    Ikezawa, Hiroki
    Suzuki, Takuya
    Nakajima, Ryo
    Dutcus, Corina E.
    Bower, John
    Ueno, Makoto
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 115 - 115
  • [4] Interim analysis of a phase 2 study of lenvatinib (LEN) monotherapy as second-line treatment in unresectable biliary tract cancer (BTC)
    Morizane, Chigusa
    Ueno, Makoto
    Sasaki, Takashi
    Nagashima, Fumio
    Mizuno, Nobumasa
    Shimizu, Satoshi
    Hayata, Nozomi
    Ikezawa, Hiroki
    Suzuki, Takuya
    Nakajima, Ryo
    Dutcus, Corina E.
    Ikeda, Masafumi
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [5] Phase II study of evofosfamide (TH-302) monotherapy as a second-line treatment in advanced biliary tract cancer
    Yoon, J. S.
    Lee, K-H.
    Cheon, G. J.
    Bang, Y-J.
    Oh, D-Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] A retrospective study for the significance of second-line therapy for unresectable or recurrent biliary tract cancer
    Kawamoto, Yasuyuki
    Komatsu, Yoshito
    Yamamura, Takahiro
    Saito, Rika
    Ito, Ken
    Nakano, Shintaro
    Harada, Kazuaki
    Yuki, Satoshi
    Kuwatani, Masaki
    Sakamoto, Naoya
    ANNALS OF ONCOLOGY, 2021, 32 : S333 - S333
  • [7] A Retrospective Study of S-1 Monotherapy as Second-line Treatment for Patients with Advanced Biliary Tract Cancer
    Kobayashi, Satoshi
    Ueno, Makoto
    Ohkawa, Shinichi
    Andou, Tomoko
    Kameda, Ryo
    Yamamoto, Naoto
    Morinaga, Soichiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (09) : 800 - 806
  • [8] Lenvatinib as second-line treatment in patients with unresectable hepatocellular carcinoma: A retrospective analysis
    Qin, He-nan
    Ning, Zhen
    Sun, Rui
    Jin, Chen-xing
    Guo, Xin
    Wang, A-man
    Liu, Ji-wei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] RETROSPECTIVE ANALYSIS OF SECOND-LINE CHEMOTHERAPY IN BILIARY TRACT CANCER
    Lucchesi, Maurizio
    Vasile, Enrico
    Caponi, Sara
    Ginocchi, Laura
    Caparello, Chiara
    Lencioni, Monica
    Ricci, Sergio
    Falcone, Alfredo
    ANNALS OF ONCOLOGY, 2011, 22 : v81 - v81
  • [10] Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment
    Richard Kim
    E Gabriela Chiorean
    Manik Amin
    Caio Max S Rocha-Lima
    Jitendra Gandhi
    William P Harris
    Tao Song
    David Portnoy
    British Journal of Cancer, 2017, 117 : 189 - 194
12345